Prospective evaluation of fluciclovine ( 18 F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients-Reference-Cited by-同舟云学术

Prospective evaluation of fluciclovine ( 18 F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients

Published:2018-05 Issue: Volume:102 Page:1-8
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Akin-Akintayo Oladunni,Tade Funmilayo,Mittal Pardeep,Moreno Courtney,Nieh Peter T.,Rossi Peter,Patil Dattatraya,Halkar Raghuveer,Fei Baowei,Master Viraj,Jani Ashesh B.,Kitajima Hiroumi,Osunkoya Adeboye O.,Ormenisan-Gherasim Claudia,Goodman Mark M.,Schuster David M.

Funder

National Institutes of Health

Blue Earth Diagnostics Ltd.

Nihon Medi-Physics Co., Ltd.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference30 articles.

1. Prostate cancer, version 1. 2016;Mohler;J. Natl. Compr. Cancer Netw.,2016

2. Imaging of prostate carcinoma;Outwater;Cancer Control: J. Moffitt Cancer Center,2013

3. Imaging for prostate cancer recurrence;Maurer;Eur. Urol. Focus,2016